Farag Halgord Ali M, Baqi Hardi Rafat, Qadir Syamand Ahmed, El Bilbeisi Abdel Hamid, Hamafarj Kawa Khwarahm, Taleb Mahmoud, El Afifi Amany
Nursing Department, Technical College of Health, Research Center, Sulaimani Polytechnic University, Sulaimani, Iraq.
Medical Laboratory Science, Technical College of Applied Sciences, Research Center, Sulaimani Polytechnic University, Sulaimani, Kurdistan, Iraq.
SAGE Open Med. 2020 Nov 27;8:2050312120965780. doi: 10.1177/2050312120965780. eCollection 2020.
This study was employed to assess the effects of Ramadan fasting on anthropometric measures, blood pressure, and lipid profile among hypertensive patients.
This cross-sectional study was conducted among a representative sample, which was selected using a census survey of hypertensive patients (both gender, aged 25-50 years, on regular antihypertensive drugs (atenolol: 50 mg orally once a day)), during Ramadan month that was falling in April to May 2020. The patients were receiving care at Halabja hospital in the Kurdistan region of Iraq. All patients were assessed in two phase's baseline (a week before Ramadan) and end stage (a week after Ramadan), using anthropometric indices, physical examination, biochemical tests, and a structured questionnaire. Statistical analysis was performed using SPSS version 21.
A total of 120 hypertensive patients were included in the study (50% females and 50% males), with a mean age of 37.5 ± 6.6 years. The major finding of our study was the significant decrease in blood pressure (P < 0.001). Furthermore, the body weight, body mass index, and waist circumference of the participants decreased after Ramadan fasting in a significant approach (P < 0.001 for all). However, for the lipid profile components, the total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol change persisted not statistically significant (P > 0.05), while only triglyceride decreased drastically after Ramadan fasting (P < 0.001).
Ramadan fasting could contribute in the improvement of blood pressure and lowers triglyceride levels, body weight, body mass index, and waist circumference of adult hypertensive patients.
本研究旨在评估斋月禁食对高血压患者人体测量指标、血压和血脂谱的影响。
本横断面研究在一个具有代表性的样本中进行,该样本是通过对高血压患者(年龄在25 - 50岁之间、男女不限、正在服用常规降压药物(阿替洛尔:每日口服50毫克))进行普查选取的,研究时间为2020年4月至5月的斋月期间。患者在伊拉克库尔德地区的哈拉布贾医院接受治疗。所有患者在两个阶段接受评估,即基线期(斋月前一周)和末期(斋月后一周),评估指标包括人体测量指数、体格检查、生化检测和一份结构化问卷。使用SPSS 21版进行统计分析。
本研究共纳入120名高血压患者(50%为女性,50%为男性),平均年龄为37.5 ± 6.6岁。我们研究的主要发现是血压显著下降(P < 0.001)。此外,斋月禁食后,参与者的体重、体重指数和腰围均显著下降(所有指标P < 0.001)。然而,对于血脂谱成分,总胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇的变化无统计学意义(P > 0.05),而仅斋月禁食后甘油三酯大幅下降(P < 0.001)。
斋月禁食有助于改善成年高血压患者的血压,降低甘油三酯水平、体重、体重指数和腰围。